Tiny, everyday messages on your phone might be quietly changing the future of diabetes care.
Texting your way to better diabetes control
A recent large analysis of research suggests that simple, structured text message reminders and coaching nudges can help many adults with diabetes bring their blood sugar under better control over time. Instead of complex apps or expensive gadgets, these interventions rely on something almost everyone already uses: basic SMS messages. The review pulled together data from more than 7,600 people and found that, overall, text-based support was linked to steady improvements in hemoglobin A1c (HbA1c), the key lab marker used to track average blood sugar over several months.
Noticeable improvements within months
Across 14 studies that tracked people for about three months, those who received diabetes-related text messages achieved, on average, an additional 0.29 percentage-point drop in HbA1c compared with people who continued with usual care alone. In practical terms, that might mean someone going from an HbA1c of 8.5% to 8.2% instead of 8.3%—a change that sounds small on paper but adds up when multiplied across large numbers of patients.
When researchers looked at roughly six-month outcomes across 20 trials, the effect was still there but a bit smaller, with about a 0.19 percentage-point greater reduction in HbA1c in the texting groups compared with standard care. But here’s where it gets controversial: some might look at these decimal-level changes and wonder whether they really matter, yet experts caution that even a 0.2–0.3% shift can meaningfully lower the risk of heart disease and small-blood-vessel complications when applied across an entire population.
Why small changes still matter
On an individual level, a 0.2–0.3% reduction in HbA1c may not feel dramatic, especially compared with big medication changes. However, when thousands or millions of people achieve even modest improvements, the combined impact can translate into fewer heart attacks, strokes, kidney problems, and vision issues over time.
For health systems and policymakers, this is a critical point: low-cost, scalable tools that nudge HbA1c down even slightly can help reduce the long-term burden of diabetes complications and related healthcare costs. And this is the part most people miss: the value of these interventions isn’t only in the size of the effect for one person, but in the cumulative benefit across entire communities.
The fade-out effect after a year
By the 12-month mark, the picture changes: the added benefit of texting programs seems to fade and is no longer statistically significant in the combined data. In other words, the early gains in HbA1c do not clearly continue to grow—and may even plateau—if the texting strategy doesn’t evolve over time.
This raises a big question: do people simply get used to the messages and start ignoring them, the same way many ignore app notifications after a while? Researchers suggest that these programs may need fresh designs, stronger engagement strategies, or pairing with other tools—like apps, coaching calls, or connected devices—to keep people interested and motivated over the long haul.
Biggest benefits for those struggling most
The review found especially strong results in participants who started with higher HbA1c levels—specifically, 8.6% or above. In this higher-risk group, tailored text messages led to about a 0.48-point greater HbA1c reduction at three months, and about a 0.36-point greater reduction at six months, compared with standard care alone.
This suggests that text-based reminders and brief coaching prompts might be particularly powerful for people having the toughest time with blood sugar control, such as those missing medications, struggling with lifestyle changes, or feeling overwhelmed by day-to-day management. A short message like “Don’t forget your evening dose” or “How did your lunch choices go today?” can serve as a gentle nudge, a bit of accountability, and an ongoing reminder that their health is a priority.
A low-cost tool almost anyone can use
One of the biggest advantages of texting is its accessibility: nearly all mobile phones can receive SMS messages, regardless of age, income level, or whether someone owns a smartphone. Texts are usually inexpensive to send, simple to read, and far less intimidating than learning a new app or device, which makes them appealing for both patients and healthcare providers.
Because of this, the authors of the analysis argue that text messaging could be a valuable add-on to routine diabetes care, especially in primary care clinics and community settings where time and resources are limited. For example, a clinic might automatically enroll patients with higher HbA1c levels into a text program that sends medication reminders, lifestyle tips, and prompts to check blood sugar or schedule follow-up visits.
What still needs to be improved
Despite the promising results, the researchers emphasize that future studies need to be higher quality and better designed. They call for trials that track people for longer periods and dig deeper into which types of messages, frequencies, and personalization approaches work best, and for whom.
Another key priority is integrating text messaging with newer diabetes technologies, such as continuous glucose monitors, connected glucose meters, and digital coaching platforms. Imagine getting a text that responds to your actual blood sugar pattern—such as a supportive message after a high reading or a reminder when you’re trending low—rather than generic tips; that kind of personalization could potentially keep people engaged longer and improve results.
A controversial question for the future
The findings come from a systematic review and meta-analysis by Pirouzmand and colleagues, published in BMJ Open Diabetes Research & Care in 2025, which concluded that text messaging interventions are associated with reductions in HbA1c among people with diabetes. The work sits under a Creative Commons Attribution-Non Commercial 4.0 License, which supports sharing and adaptation for non-commercial use as long as proper credit is given.
Here’s the provocative part: should healthcare systems invest heavily in simple text messaging programs when newer, more advanced digital tools are emerging—or is it precisely their simplicity and low cost that make texts the smarter long-term bet? What do you think: are text messages an underrated, high-impact tool that health systems should scale up, or are they a short-term fix that will need to be replaced by more sophisticated solutions soon? Share where you stand—do you strongly agree with using texting as a core part of diabetes care, or do you think its benefits are overhyped?
